慢性丙型肝炎患者血清HCV-Cag检测及其临床意义

doi:10.3969/j.issn.1672-5069.2014.04.022

Abstract

Wang Xueyan, Wang Fudang, Suo Zhimin. Detection of serum hepatitis C virus core antigen in patients with?chronic?hepatitis C[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(4): 414-416.

[1] 张国海,梁丽英,许瑞安. RNA干扰抗丙型肝炎病毒的研究进展. 重庆医学,2010,39（14）：1914-1917.
[2] 李世荣,邱玉中,杨建文,等. 献血员聚集地区人群HCV感染影响因素的非条件Logistic回归分析. 现代预防医学,2005,32（6）：618-620.
[3] 张萧. 临床检验中丙型肝炎病毒的常用检测项目及意义.中国当代医药,2011,18（15）：14-15.
[4] 张效本,阮秀花,田葱. 142例慢性丙型肝炎患者血清HCV-cag和HCV RNA检测结果分析. 实用肝脏病杂志,2013,16（4）：358-359.
[5] 谭晓霞,纪勇平,骆昊翠.丙型肝炎病毒核心抗原检测的临床应用价值. 检验医学,2010,25（2）：134-136.
[6] Bouvier-Alias M,Patel K,Dahari H,et al. Clinical utility of total HCV core antigen quantification:a new indirect marker of HCV replication. Hepatology,2002,36（1）：211-218.
[7] 中华医学会肝病学分会和感染病学分会.丙型肝炎防治指南. 中华肝脏病杂志,2004,12（4）：194-198.
[8] 曹红. 丙型肝炎的诊断. 实用肝脏病杂志,2012,15（5）：382-383.
[9] 李华,龙润乡,杨蓉,等. HCV不同标志物检测结果比较分析. 医学研究杂志,2012,41（6）：17-20.
[10] 黄锦江,杨静,刘小琦. HCV核心抗原检测用于丙型肝炎早期诊断的价值评估. 现代检验医学杂志,2011,26（2）：99-100.
[11] 钟锐兴, 赖春颜,梁东,等. 酶免疫法检测丙型肝炎病毒核心抗原的应用价值. 现代医药卫生,2009,25（7）：1030-1031.
[12] 王成宝,聂红明,吕桦,等. 慢性丙型肝炎病毒清除率与性别和年龄的关系. 实用医学杂志,2011,27（21）：3851-3853.
[13] 周友乾,尹凤鸣,冯经华. 丙型肝炎病毒载量与基因型和抗病毒疗效的关系研究. 实用肝脏病杂志,2011,15（5）：340-343.
[14] 黄敏,张敏丽,蒲晓允. 同步检测两种输血传播病原体的蛋白微阵列的研究. 重医学,2007,36（10）：914-915.
[15] 李金平. 丙型肝炎病毒核心抗原与丙型肝炎抗体联合检测在丙型肝炎诊疗中的作用. 检验医学与临床,2011,8（13）：1575-1577.

Detection of serum hepatitis C virus core antigen in patients with?chronic?hepatitis C

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Jiang Yi, Liu Bing. Comparison of clinical features and histopathological activity index between patients with chronic hepatitis B and chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 188-191.
[2]	Wu Jing, Dong Baoji, Wu Chao. Comparison of PD-1 receptor on peripheral blood follicular helper T lymphocyte surface in chronic hepatitis C patients with low and high serum viral loads [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 192-195.
[3]	Hou Chunyang, Ma Yumei, Li Fangzhi.. Clinical efficacy of peg-IFNα and ribavirin combination in treating patients with chronic hepatitis C and genotype one and six infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 53-56.
[4]	Jiao Fangzhou, Zhang Haiyue, Zhang Wenbin, et al. Efficacy of combination sofosbuvir and pegylated interferon-α in treatment of patients with chronic hepatitis C:a Meta-analysis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 220-224.
[5]	Tao Guoyun, Ai Lisha, Zhang Li. Prediction of sustained virologic response by surveillance of serum ribavirin concentration in chronic hepatitis C patients with genotype 1b infection receiving standardized antiviral therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 287-288.
[6]	Zhu Chuanlong，Zhu Tiantian，Wang Kung，et al.. Serum Pygo2 levels as an indicator of liver fibrosis in patients with chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 161-164.
[7]	Feng Xiaoxia，Nie Yuanxia，Liang Hailin.. Impact of Yiqi Jiedu Huayu compound combined with antiviral therapy on peripheral blood lymphocyte subsets and inflammatory cytokines in patients with refractory chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 674-677.
[8]	Guo Zhaoxia，Wang Yuzhen，Su Shaohui.. Prevalence of cardiovascular diseases in patients with chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 757-761.
[9]	Zhu Guobing， Wu Linling， Tian Tian， et al.. Risk factors of thyroid?diseases in patients with chronic hepatitis C and hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(6): 669-671.
[10]	zhu Yanfang，Gong Li，Fu Maoying. Combination of Zhenqi Fuzheng granule and peg-interferon alpha-2a in the treatment of patients with chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(4): 430-431.
[11]	Fan Jiangao. Highlights of Journal of Practical Hepatology in 2014 [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(1): 4-5.
[12]	Wu Di, Ning Qin. 2014 update on the diagnosis and treatment of chronic viral hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(1): 10-14.
[13]	Wu Shuduo, Jiang Junmin, Tian Guangjun. Efficacy of peanut garment decoction on bone marrow suppression caused by interferon-alpha in the treatment of patients with chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(4): 412-414.
[14]	Xia Dongli, Ma Hailin, Shi Xiujiang. Ozone-enriched autologous blood transfusion significantly reduce adverse reactions in chronic hepatitis C patients receiving interferon-α and ribavirin therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(3): 259-263.
[15]	Li Jianping，Guan Yujuan，Hong Wenxin，et al.. Efficacy and influence factors of pegylated interferon alpha-2a plus ribavirin for treatment of patients with chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(2): 149-153.